<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02369211</url>
  </required_header>
  <id_info>
    <org_study_id>2014P002749</org_study_id>
    <nct_id>NCT02369211</nct_id>
  </id_info>
  <brief_title>Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)</brief_title>
  <official_title>Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV) in Patients Undergoing Robotic-assisted Laparoscopic Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mallinckrodt</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine pharmacoeconomics of IV acetaminophen (Ofirmev). Specifically, to examine its
      potential to improve hospital efficiency and patient outcomes. The investigators compare the
      addition of IV acetaminophen versus placebo on postoperative anesthesia care unit recovery
      times, inpatient hospital length of stay (LOS), postoperative pain scores, consumption of
      opiates as rescue agents and side effects among patients undergoing robotic-assisted
      laparoscopic prostatectomy (RALP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although IV acetaminophen has been studied in urologic surgery, it has not been studied
      specifically in prostatectomies, and therefore there are no outcomes or cost-effectiveness
      data currently available. In addition, the current trend is to perform prostatectomy with a
      robot-assisted laparoscopic technique to help minimize incision size, blood loss,
      postoperative pain, and speed up patient recovery. Current literature only includes the use
      of opioids in the perioperative setting for robot-assisted prostatectomy to treat pain, but
      only a small trial used oral acetaminophen as a measure for analgesia in RALP. In addition to
      the decreasing use of opioids in perioperative pain management, emphasis has been placed on
      reducing costs of healthcare. A major contributor to this issue is hospital length of stay
      (LOS) and there has been increased pressure on healthcare providers to decrease overall LOS.
      Several factors may contribute to hospital LOS, including hospital acquired infections,
      surgical recovery, wound care, other surgical and anesthesia-related complications, and
      importantly, inadequate pain control.

      In this study we examine the impact of adding IV acetaminophen to the multimodal analgesic
      regimen for robotic-assisted laparoscopic prostatectomy (RALP). Our hypothesis is that the
      addition of IV acetaminophen can improve postoperative recovery time, inpatient LOS,
      postoperative pain scores, and opioid consumption.

      This study specifically addresses pharmacoeconomics of IV acetaminophen. The goal is to
      understand its potential to improve hospital efficiency and patient outcomes. The study
      compares the impact of the addition of IV acetaminophen versus a placebo on postoperative
      anesthesia care unit recovery times, inpatient LOS, postoperative pain scores, consumption of
      opiates as rescue agents and side effects in patients undergoing RALP.

      The study is a 2-arm, double-blind, randomized, placebo controlled trial comparing IV
      acetaminophen to a control (IV placebo). All patients in this study were scheduled to undergo
      RALP.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Anesthesia Care Unit Length of Stay</measure>
    <time_frame>approximately 30-240 min</time_frame>
    <description>The amount of time patients stayed in the post-anesthesia care unit following anesthesia, before going to the inpatient ward.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>1-3 days</time_frame>
    <description>This outcome measure calculates the number of days the patient stayed in the hospital before being discharged home.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>0-24 hours after surgery</time_frame>
    <description>Pain scores were collected using the Visual Analog Scale. The scale range is 0 (no pain) to 10 (most pain).
Mean pain score over first 24 hours postoperatively was collected.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Use</measure>
    <time_frame>0-24 hours</time_frame>
    <description>A measure of the amount of opioid study patients used postoperatively while recovering from surgery at the hospital</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Prostatectomy</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Intravenous acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient receives 1g intravenous acetaminophen after the incision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient receives saline injection instead of the study drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen (Ofirmev)</intervention_name>
    <description>The patient was administered IV Ofirmev during anesthesia and then 3 more IV doses (1g each) every 6 hours up to 24 hrs.</description>
    <arm_group_label>Intravenous acetaminophen</arm_group_label>
    <other_name>Ofirmev</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The patient was administered IV Placebo during anesthesia and then 3 more doses of IV Placebo every 6 hours up to 24 hrs.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing robotic-assisted laparoscopic prostatectomy

          -  â‰¥18 years old males

          -  American Society of Anesthesiologists class 1-4

        Exclusion Criteria:

          -  Chronic opiate use

          -  Liver disease (known history of hepatitis B or C, cirrhosis, nonalcoholic
             steatohepatitis, history of alcoholism, liver function test results greater than 3
             times upper limit of normal in the past 3 months)

          -  Allergy/hypersensitivity to acetaminophen

          -  Patients with baseline dementia

          -  Chronic diathesis

          -  Chronic kidney disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Urman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>February 17, 2015</study_first_submitted>
  <study_first_submitted_qc>February 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2015</study_first_posted>
  <results_first_submitted>August 3, 2019</results_first_submitted>
  <results_first_submitted_qc>September 10, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 11, 2019</results_first_posted>
  <last_update_submitted>September 10, 2019</last_update_submitted>
  <last_update_submitted_qc>September 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Richard D Urman</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesia</investigator_title>
  </responsible_party>
  <keyword>acetaminophen</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 16, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT02369211/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited in the preoperative assessment clinic prior to undergoing surgery</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Intravenous Acetaminophen</title>
          <description>Patient receives 1g intravenous acetaminophen after the incision
Acetaminophen (Ofirmev)</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Patient receives saline injection instead of the study drug
Placebo</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>analysis population is the same as the assignment in Participant flow</population>
      <group_list>
        <group group_id="B1">
          <title>Intravenous Acetaminophen</title>
          <description>Patient receives 1g intravenous acetaminophen after the incision
Acetaminophen (Ofirmev)</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Patient receives saline injection instead of the study drug
Placebo</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="43"/>
            <count group_id="B2" value="41"/>
            <count group_id="B3" value="84"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="43"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="84"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="43"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="84"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.6" spread="6.1"/>
                    <measurement group_id="B2" value="60.2" spread="6.3"/>
                    <measurement group_id="B3" value="61.7" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="43"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="84"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="43"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="84"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post Anesthesia Care Unit Length of Stay</title>
        <description>The amount of time patients stayed in the post-anesthesia care unit following anesthesia, before going to the inpatient ward.</description>
        <time_frame>approximately 30-240 min</time_frame>
        <population>Patients who had surgery and were then transferred to the post-anesthesia care unit for recovery.</population>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Acetaminophen</title>
            <description>Patient receives 1g intravenous acetaminophen after the incision
Acetaminophen (Ofirmev)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patient receives saline injection instead of the study drug
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Post Anesthesia Care Unit Length of Stay</title>
          <description>The amount of time patients stayed in the post-anesthesia care unit following anesthesia, before going to the inpatient ward.</description>
          <population>Patients who had surgery and were then transferred to the post-anesthesia care unit for recovery.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124" spread="58.26"/>
                    <measurement group_id="O2" value="132" spread="62.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Hospital Length of Stay</title>
        <description>This outcome measure calculates the number of days the patient stayed in the hospital before being discharged home.</description>
        <time_frame>1-3 days</time_frame>
        <population>Patients who were admitted to the hospital (as inpatients) following surgery and post-anesthesia care unit stay.</population>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Acetaminophen</title>
            <description>Patient receives 1g intravenous acetaminophen after the incision
Acetaminophen (Ofirmev)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patient receives saline injection instead of the study drug
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Length of Stay</title>
          <description>This outcome measure calculates the number of days the patient stayed in the hospital before being discharged home.</description>
          <population>Patients who were admitted to the hospital (as inpatients) following surgery and post-anesthesia care unit stay.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" lower_limit="0.71" upper_limit="0.90"/>
                    <measurement group_id="O2" value="0.82" lower_limit="0.66" upper_limit="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score</title>
        <description>Pain scores were collected using the Visual Analog Scale. The scale range is 0 (no pain) to 10 (most pain).
Mean pain score over first 24 hours postoperatively was collected.</description>
        <time_frame>0-24 hours after surgery</time_frame>
        <population>Patients who were assessed for levels of pain following surgery, including both treatment and placebo arms.</population>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Acetaminophen</title>
            <description>Patient receives 1g intravenous acetaminophen after the incision
Acetaminophen (Ofirmev)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patient receives saline injection instead of the study drug
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score</title>
          <description>Pain scores were collected using the Visual Analog Scale. The scale range is 0 (no pain) to 10 (most pain).
Mean pain score over first 24 hours postoperatively was collected.</description>
          <population>Patients who were assessed for levels of pain following surgery, including both treatment and placebo arms.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.62" lower_limit="0.13" upper_limit="1.00"/>
                    <measurement group_id="O2" value="0.88" lower_limit="0.38" upper_limit="2.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Use</title>
        <description>A measure of the amount of opioid study patients used postoperatively while recovering from surgery at the hospital</description>
        <time_frame>0-24 hours</time_frame>
        <population>Patients who underwent surgery and stayed in the hospital as inpatients and received pain management.</population>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Acetaminophen</title>
            <description>Patient receives 1g intravenous acetaminophen after the incision
Acetaminophen (Ofirmev)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patient receives saline injection instead of the study drug
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Use</title>
          <description>A measure of the amount of opioid study patients used postoperatively while recovering from surgery at the hospital</description>
          <population>Patients who underwent surgery and stayed in the hospital as inpatients and received pain management.</population>
          <units>morphine milligram equivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="36.4" upper_limit="50.0"/>
                    <measurement group_id="O2" value="50" lower_limit="35.6" upper_limit="72.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Patients were followed for 30 days after surgery for which adverse events were collected.</time_frame>
      <desc>Same definition of adverse event was used.</desc>
      <group_list>
        <group group_id="E1">
          <title>Intravenous Acetaminophen</title>
          <description>Patient receives 1g intravenous acetaminophen after the incision
Acetaminophen (Ofirmev)</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Patient receives saline injection instead of the study drug
Placebo</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>James Webber</name_or_title>
      <organization>Brigham and Women's Hospital</organization>
      <phone>(617) 732-6877</phone>
      <email>jwebber1@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

